Professional Documents
Culture Documents
1688-Article Text-2913-1-10-20181127 PDF
1688-Article Text-2913-1-10-20181127 PDF
different APIs (active pharmaceutical ingredients) the additives should be checked before
are designed for children and the elderly who formulation design and manufacturing.
has complexity in tablets swallowing. It has been
reported that dysphasia is frequent among all DESIRED CHARACTERISTICS AND
age groups of patients but it is more specific to DEVELOPMENTAL CHALLENGES OF FAST
pediatrics and geriatrics populations. DISPERSIBLE TABLET
TASTE OF ACTIVE COMPOUND
Fast dispersable tablets are categorized into two Taste is one of the most widely utilized features
types: for the administration of oral solid dosage form.
• Water dispersable tablets Bad taste is a major concern which is normally
• Mouth dissolving tablets observed in several active compounds. Different
techniques are adopted for improving the taste
a. Water dispersable tablets which may resulted in much enhanced palatability
These types of tablets disintegrate quickly in of oral dosage forms. Masking of bad taste can
the water to produce the suspension. be achieved by the addition of taste masking
b. Mouth dissolving tablets constituents.10
These types of tablets are differentiated by
dissolving in the mouth.7 FEATURES OF ACTIVE COMPOUND
Several features of active compound may affect
Advantages of Fast Dispersable Tablets the attributes of fast dispersible tablet i.e. crystal
These formulations are designed for children morphology of the compound, hygroscopic
and the elderly who has complexity in tablets nature, solubility, compaction characteristics,
swallowing. It has been reported that dysphasia particle size and true and bulk density could
is frequent among all age groups of patients but significantly affect the physico-chemical
it is more specific to pediatrics and geriatrics properties of tablets.11
populations. Dispersible tablets can be used
easily by geriatrics and pediatrics patients.8 PROPERTIES OF FILLERS / BINDERS
Usually fillers / binders are involved in a several
Candidates for Disintegrating Formulations complex mechanisms during dissolution that
The features should be: generally starts when the medium comes in
1. Good solubility both in water and saliva. contact with the compound and then penetrate
2. At the oral cavity pH it should be partially non- deep in to the matrix. Usually effects of excipients
ionized. are related with the structure and surface
3. Compound should diffuse and partition into properties of the solid particles.12
the upper GIT epithelium.
4. Compound should easily permeate into the TABLET DEAGGREGATION PHENOMENA
oral mucosal tissue. Various parameters of tablets i.e. friability,
5. Short half-life and repeated dosing.9 hardness and disintegration can be influenced
by applied compressional force and excipients
Issues Related To The Fast Absorption of properties which can affect the tablet porosity.
Drugs Addition of disintegrants in tablet formulation is to
If a tablet releases the drug too quickly, the blood accelerate the process of disintegration.11
level of the drug may vary.
DIFFERENT METHODS USED FOR THE
Strategies to Develop Safer Formulations DEVELOPMENT OF FAST DISINTEGRATING
1. In order to avoid the variation in blood levels TABLETS
the formulation design and manufacturing i. Molding methods
should be considered. ii. Compaction methods such as such as Direct
2. Also the physico-chemical properties of Compression, Dry Granulation and Wet
Professional Med J 2016;23(9): 1022-1025. www.theprofesional.com 1023
BRUCELLOSIS 3
5. Baird R and Sally F. Microbial Quality Assurance in 14. Samprasita W, Akkaramongkolporna P, Ngawhirunpata
Pharmaceuticals, Cosmetics, and Toiletries, 1996, T, Rojanarataa T and Opanasopit P. Formulation
Edition 2nd, Taylor and Francis limited, 127. and evaluation of meloxicam oral disintegrating
tablet with dissolution enhanced by combination
6. Modi D, Amaliyar P, Kalal Y, Gangadia B, Chaudhary of cyclodextrin and ion exchange resins. Drug
S, Sanghvi K, Shah H, Sen D. Novel Approach in Development and Industrial Pharmacy. 2015, 41 (6):
Compressed-coated Tablet Dosage Form: Core-in- 1006-1016.
Cup (In Lay) Tablet with Geometrically Altered Drug
Delivery Concept. British biomedical bulletin. 2013, 1 15. Kulkarni SV, Kumar R, Patel N, Rao S, Ramesh B, Kumar
(2): 090-102. A. Formulation and evaluation of fast disintegrating
meloxicam tablets and its comparison with marketed
7. Schiermeier S, Schmidt PC. Fast dispersible Ibuprofen product. International Journal of Pharmacy and
tablets. European Journal of Pharmaceutical Pharmaceutical Sciences. 2011, 3 (1): 91-93.
Sciences. 2002, 15: 295–305.
16. El-Mahrouk GM, Aboul-Einien MH, ElKasabgy NA.
8. Mizumoto T, Masuda Y, Takeshi Y, Estuo Y and Katsuhide Formulation and evaluation of meloxicam orally
T. Formulation design of a novel fast disintegrating dispersible capsules. Asian Journal of Pharmaceutical
tablet. Int J Pharm. 2005, 306 (12): 83–90. Science. 2009, 4:8-22.
9. Velmurugan S and Vinushitha S. Oral Disintegrating 17. Rangasamy M, Balasubramaniam A and Gummadevelly
Tablets: An Overview. International Journal of Chemical S. Design and Evaluation of β-cyclodextrin
and Pharmaceutical Sciences. 2010, 1(2): 1-12. Complexes of Meloxicam Tablet. Research J. Pharm.
and Tech. 2008, 1(4): 485-486.
10. Sohi H, Sultana Y, Khar RK. Taste masking technologies
in oral pharmaceuticals: Recent developments and 18. Inamdar N, Bhise K, Memon S. Solubility enhancement
approaches. Drug Dev Ind Pharm. 2004, 30:429–48. and development of dispersible tablet of meloxicam.
Asian journal of Pharmaceutics. 2008, 2 (2): 128-132.
11. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast
disintegrating tablets: Developments, technologies, 19. Dehghana MHG and Jafarb M. Improving Dissolution
taste-masking and clinical studies. Crit Rev Ther Drug of Meloxicam Using Solid Dispersions. Iranian
Carrier Syst. 2004, 21:433–76. Journal of Pharmaceutical Research. 2006, 4: 231-238.
12. Jinichi F, Etsuo Y, Yasuo Y, Katsuhide T. Evaluation of 20. Bolhuis GK, Armstrong NA. Anthony Armstrong.
rapidly disintegrating tablets containing glycine Excipients for Direct Compaction - an Update.
and carboxymethylcellulose. Inter J Pharm. 2006, Pharmaceutical Development and Technology. 2006,
310:101–109. 11:111–124.
13. Dey P and Maiti S. Orodispersible tablets: A new 21. Mangal M, Thakral S, Goswami M, Ghai P.
trend in drug delivery. J Nat Sci Biol Med. 2010, 1 (1): Superdisintegrants: An Updated Review. International
2-5. Journal of Pharmacy and Pharmaceutical Science
Research. 2012, 2(2): 26-35.